20 midcap stocks with 2024 upside ranging up to 62%, according to analysts MarketWatch Dec 30, 2023 12:02pm
20 midcap stocks with 2024 upside ranging up to 62%, according to analysts MarketWatch Dec 26, 2023 6:02pm
Lantheus and Point Biopharma shares drop on prostate cancer treatment data MarketWatch Dec 18, 2023 1:54pm